ResMed Inc
(OTCPK:RSMDF)
$
16.72
(0%)
Market Cap: 31.68 Bil
Enterprise Value: 29.59 Bil
PE Ratio: 20.22
PB Ratio: 4.68
GF Score: 94/100 Resmed Inc at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Sep 19, 2019 / 10:25AM GMT
Release Date Price:
$13.27
Lyanne Harrison
BofA Merrill Lynch, Research Division - VP
Good morning, gentlemen, and welcome to our conversation with ResMed. I am Lyanne Harrison and I cover healthcare in Australia. And today, I have with me Robert Douglas; COO of ResMed; David Pendarvis, CAO; and Amy Wakeham, Head of Investor Relations.
So Rob, Dave, Amy, thank you for joining us and making your way to London.
David B. Pendarvis
ResMed Inc. - Chief Administrative Officer, Global General Counsel & Secretary
Thanks very much.
Robert A. Douglas
ResMed Inc. - President & COO
Thanks, Lyanne.
Lyanne Harrison
BofA Merrill Lynch, Research Division - VP
So for those of you who are not familiar with the ResMed story, I might get Rob to start with the presentation and an overview on ResMed.
Robert A. Douglas
ResMed Inc. - President & COO
Sure. Thanks, Lyanne. So we're just going to talk a little bit about ResMed's overall strategy in the
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot